Papa, 60, had been CEO of Perrigo since 2006
LAVAL, Que. — Embattled drug company Valeant Pharmaceuticals International Inc. has named Joseph Papa as its new chairman and chief executive.
The company says Papa, who was chairman and CEO of drug company Perrigo in the U.S., is expected to join Valeant early next month.
Read the full article at: business.financialpost.com
